Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DM1TG3C)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
NSC729360; CHEBI:258842; I14-11718; NCGC00165855-01; (2E)-5-(3-(phenylsulfonylamino)phenyl)pent-2-ene-4-ynohydroxamic acid; (2E)-5-[3-(Phenylsulfonylamino)phenyl]pent-2-en-4-ynohydroxamic Acid; (E)-5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide; 151720-43-3
| |||||
| Therapeutic Class | Anticancer Agents | |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Fibroblast
Nasopharyngeal carcinoma
|
||||||||||||||||||||||||
